| Asian Zika virus isolate significantly changes the transcriptional profile and alternative RNA splicing events in a neuroblastoma cell line G Bonenfant, R Meng, C Shotwell, P Badu, AF Payne, AT Ciota, ... Viruses 12 (5), 510, 2020 | 27 | 2020 |
| Disease-associated inosine misincorporation into RNA hinders translation JH Schroader, LA Jones, R Meng, HK Shorrock, JI Richardson, ... Nucleic Acids Research 50 (16), 9306-9318, 2022 | 8 | 2022 |
| Hemochromatosis drives acute lethal intestinal responses to hyperyersiniabactin-producing Yersinia pseudotuberculosis S Das, M Saqib, RC Meng, SV Chittur, Z Guan, F Wan, W Sun Proceedings of the National Academy of Sciences 119 (2), e2110166119, 2022 | 7 | 2022 |
| Asian Zika Virus Isolate Significantly Changes the Transcriptional Profile and Alternative RNA Splicing Events in a Neuroblastoma Cell Line. Viruses. 2020; 12 (5): 510 G Bonenfant, R Meng, C Shotwell, P Badu, AF Payne, AT Ciota, ... PubMed Abstract| Publisher Full Text| Free Full Text, 0 | 5 | |
| Identification of clinically actionable biomarkers via routine comprehensive genomic profiling across a large community health system. RK Weerasinghe, R Meng, AK Dowdell, B Bapat, A Vita, B Schroeder, ... Journal of Clinical Oncology 40 (16_suppl), e15035-e15035, 2022 | 3 | 2022 |
| Oral microbiota analyses of paediatric Saudi population reveals signatures of dental caries YM Alyousef, S Piotrowski, FA Alonaizan, A Alsulaiman, AA Alali, ... BMC Oral Health 23 (1), 935, 2023 | 2 | 2023 |
| Improved outcomes from reflex comprehensive genomic profiling-guided precision therapeutic selection across a major US healthcare system. B Piening, B Bapat, RK Weerasinghe, R Meng, AK Dowdell, SC Chang, ... Journal of Clinical Oncology 41 (16_suppl), 6622-6622, 2023 | 2 | 2023 |
| FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies D Knorr, R Leidner, S Jensen, R Meng, A Jones, C Ballesteros-Merino, ... bioRxiv, 2023 | 2 | 2023 |
| Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population RM Alsulaiman, AA Al-Quorain, FA Al-Muhanna, S Piotrowski, EA Kurdi, ... BMC gastroenterology 23 (1), 258, 2023 | 1 | 2023 |
| 113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy N Iwamoto, T Shimada, T Moudgil, R Meng, T Christie, A Dowell, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1+/-GITR in head & neck cancer: safety, efficacy, and … RS Leidner, C Paustian, SM Jensen, T Moudgil, Y Koguchi, N Simons, ... Cancer Research 84 (7_Supplement), CT112-CT112, 2024 | | 2024 |
| FcγRIIB is an immune checkpoint limiting the activity of Treg-targeting antibodies in the tumor microenvironment DA Knorr, L Blanchard, RS Leidner, SM Jensen, R Meng, A Jones, ... Cancer immunology research 12 (3), 322-333, 2024 | | 2024 |
| Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health system AK Dowdell, R Meng, A Vita, B Bapat, D Hanes, SC Chang, L Harold, ... medRxiv, 2024.01. 02.23300311, 2024 | | 2024 |
| 148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine R Meng, T Moudgil, N Iwamoto, Y Minegishi, Y Koguchi, V Rajamanickam, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma C Paustian, T Moudgil, V Rajamanickam, N Simons, R Meng, M Couey, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma MA Couey, M Taylor, T Moudgil, Y Koguchi, A Stadum, T Christie, ... Cancer Research 83 (8_Supplement), CT123-CT123, 2023 | | 2023 |
| Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine R Meng, W Redmond, C Bifulco, R Sanborn, RB Bell, W Urba, R Leidner, ... | | 2023 |
| Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy N Iwamoto, T Shimada, T Moudgil, R Meng, T Christie, A Dowdell, ... | | 2022 |
| Design and Implementation of a Decentralized Virtual Molecular Tumor Board across a Large, Diverse Community Health System B Piening, P Foley, K Matlock, H Wright, L Harold, R Weerasinghe, A Viita, ... | | 2022 |
| Clinical actionability and therapy selection for advanced NSCLC patients tested using comprehensive genomic profiling B Bapat, R Weerasinghe, R Meng, A Dowdell, SC Chang, B Schroeder, ... European Journal of Cancer 174, S97-S98, 2022 | | 2022 |
